Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study (Q33357735)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study |
scientific article |
Statements
1 reference
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study (English)
1 reference
Gunnar Juliusson
1 reference
Martin Höglund
1 reference
Karin Karlsson
1 reference
Christina Löfgren
1 reference
Lars Möllgård
1 reference
Christer Paul
1 reference
Ulf Tidefelt
1 reference
Magnus Björkholm
1 reference
Leukemia Group of Middle Sweden
1 reference
1 December 2003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference